A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants
Clinical trial NCT04851977 · COMPLETED
Trial details
- NCT number
- NCT04851977
- Sponsor
- Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2019-04-07
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.